Pages that link to "Q42408709"

The following pages link to Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa. (Q42408709):

Displaying 29 items.

• Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase (Q27647283) (← links)
• Structural Basis of the Promiscuous Inhibitor Susceptibility of Escherichia coli LpxC (Q27680233) (← links)
• Lipopolysaccharide (LPS) Inner-Core Phosphates Are Required for Complete LPS Synthesis and Transport to the Outer Membrane in Pseudomonas aeruginosa PAO1 (Q28492739) (← links)
• The periplasmic protein TolB as a potential drug target in Pseudomonas aeruginosa (Q28541613) (← links)
• Elucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulation (Q28543147) (← links)
• Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa (Q30882914) (← links)
• Active site metal ion in UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) switches between Fe(II) and Zn(II) depending on cellular conditions (Q34232001) (← links)
• LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens (Q34334699) (← links)
• Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis. (Q34497596) (← links)
• Profile of Christian R. H. Raetz (Q34706044) (← links)
• Kdo2 -lipid A: structural diversity and impact on immunopharmacology (Q35468441) (← links)
• Translating slow-binding inhibition kinetics into cellular and in vivo effects (Q35954896) (← links)
• PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. (Q36993566) (← links)
• Understanding efflux in Gram-negative bacteria: opportunities for drug discovery (Q38011247) (← links)
• Translational deficiencies in antibacterial discovery and new screening paradigms (Q38584143) (← links)
• Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC. (Q38846788) (← links)
• Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development (Q38905119) (← links)
• Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers. (Q38991210) (← links)
• In vitro and in vivo screening for novel essential cell-envelope proteins in Pseudomonas aeruginosa (Q40259276) (← links)
• Mechanisms Decreasing In Vitro Susceptibility to the LpxC Inhibitor CHIR-090 in the Gram-Negative Pathogen Pseudomonas aeruginosa (Q40325143) (← links)
• The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions (Q40519553) (← links)
• Control of lipopolysaccharide biosynthesis by FtsH-mediated proteolysis of LpxC is conserved in enterobacteria but not in all gram-negative bacteria. (Q41430702) (← links)
• The Escherichia coli rhaSR-PrhaBAD Inducible Promoter System Allows Tightly Controlled Gene Expression over a Wide Range in Pseudomonas aeruginosa (Q41620176) (← links)
• Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli (Q41821956) (← links)
• Novel genetic tools to tackle c-di-GMP-dependent signalling in Pseudomonas aeruginosa. (Q47900664) (← links)
• Pseudomonas aeruginosa LptE is crucial for LptD assembly, cell envelope integrity, antibiotic resistance and virulence (Q57795017) (← links)
• Targeting Metalloenzymes for Therapeutic Intervention (Q59830619) (← links)
• Genetic Basis and Physiological Effects of Lipid A Hydroxylation in Pseudomonas aeruginosa PAO1 (Q91963635) (← links)
• Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa (Q92881020) (← links)